Oragenics Inc.

Oragenics Inc.
Stock Exchange NYSE
EPS
$0.93
Market Cap
$22.1 M
Shares Outstanding
46.13 M
Public Float
25.69 M

Profile

Address
4902 Eisenhower boulevard
Tampa Florida 33634
United States
Employees -
Website http://www.oragenics.com
Updated 07/08/2019
Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D.

Financials

View All

Alan F. Joslyn
President, Chief Executive Officer & Director
Robert C. Koski
Director